Loading
EI
Enlitic Inc. Stock: price and insider trades · Australia
4 insiders bought €76k of shares over the last 90 days, the latest by Sergio Duchini, filed 06 Aug 2026.
Enlitic Inc.: what insiders have been doing
This page follows insider dealings at Enlitic Inc. as filed with ASX. Over the twelve months to 18 October 2026, 4 filings were filed, from 4 insiders.
The flow runs one way only: 4 insiders bought (4 purchases totalling €76k) and nobody sold on the market. The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 4 senior executives. Biggest ticket of the year: €76k, bought by Michael Sistenich and made public on 6 August 2026 (0.41% of market cap).
The latest purchase dates back some time: it was published 73 days ago, on 6 August 2026.
For context, the typical company on the same exchange (median of 2,535 companies) published 3 filings over the same period, against 4 filings here. Looking back to 2026, when coverage begins, insiders filed 4 purchases and no sales.
Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€76,325
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleLawrence Gozlan1 buy
Lisa Pettigrew1 buy
Michael Sistenich1 buy
Sergio Duchini1 buy
Since the insiders bought
- -20.0%Entry A$0.00 · Close at T+30 A$0.00
- -20.0%Entry A$0.00 · Close at T+30 A$0.00
- -20.0%Entry A$0.00 · Close at T+30 A$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.03
Analyst consensus
Income statement
RevenueA$3.8M
Gross profitA$3.8M100% margin
EBITDA-A$12.6M-333% margin
Net income-A$13.4M-352.3% margin
Valuation
P/Book0.8x
Beta-0.26
Balance sheet & cash
Market capA$24.7M
Total debtA$893.4k
Free Cash Flow-A$11.8M
Debt / Equity22%
Profitability & ownership
ROE-349.1%
ROA-67.4%
% insiders5.8%
% institutions0.5%
Last declaration on 6 August 2026
Declarations4 total
7,812,500 sharesShareASXISIN AU0000305427ASX:2924-03118627-3A698319
Canonical exit: 4 Nov 2026 (T+90)
42,750,000 sharesShareASXISIN AU0000305427ASX:2924-03118625-3A698318
Canonical exit: 3 Nov 2026 (T+90)
128,000,000 sharesShareASXISIN AU0000305427ASX:2924-03118624-3A698317
Canonical exit: 3 Nov 2026 (T+90)
31,250,000 shares@ A$0.0040.41% mcap100.0% of flowShareASXISIN AU0000305427ASX:2924-03118622-3A698316
Canonical exit: 4 Nov 2026 (T+90)
4 of 4 declarations
About Enlitic Inc.
Enlitic Inc. is a company specializing in artificial intelligence for medical imaging. It develops solutions to enhance the diagnosis and treatment of diseases using advanced technologies.
